TP53 and cancer: Aggregated species of mutant p53, or in another word, oligomerization of p53 mutants, are highly expressed in cancer cells, and accumulate as amyloid oligomers, which are associated with malignant phenotypes such as chemoresistance and tumor growth (Melo Dos Santos et al., 2019; Pedrote et al., 2020; Zhang et al., 2020).